PULMONARY FIBROSIS FOUNDATION: Form 990, tax year 2021

View the entire original 990 at ProPublica ↗

Organization
PULMONARY FIBROSIS FOUNDATION (EIN 84-1558631)
Tax period
2021-07-01 to 2022-06-30
Filed
2023-03-31
IRS object ID
202320909349301012
Schema version
2021v4.2
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2023-03-31T11:41:49-05:00ReturnTs
Tax Period End2022-06-30TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1BDO USA LLPBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line1330 N Wabash Suite 3200AddressLine1Txt
CityCHICAGOCityNm
State AbbreviationILStateAbbreviationCd
ZIP60611ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2021-07-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN841558631EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1Pulmonary Fibrosis FoundationBusinessNameLine1Txt
FieldValueIRS element (for citing)
In Care Of% SCOTT STASZAK COOInCareOfNm
Business Name ControlPULMBusinessNameControlTxt
Phone3122652182PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1230 East Ohio Street Suite 500AddressLine1Txt
CityChicagoCityNm
State AbbreviationILStateAbbreviationCd
ZIP606113270ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonScott StaszakPersonNm
Person TitleCOOPersonTitleTxt
Phone3125879272PhoneNum
Signature2023-03-28SignatureDt
Discuss With Paid PreparerYes (true)DiscussWithPaidPreparerInd

Signing Officer SigningOfficerGrp

Person Full Name PersonFullName

FieldValueIRS element (for citing)
Person FirstScottPersonFirstNm
Person LastStaszakPersonLastNm
FieldValueIRS element (for citing)
SSN999009999SSN

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonJacob CookPreparerPersonNm
PTINP01240455PTIN
Phone3128569100PhoneNum

Additional Filer Information AdditionalFilerInformation

Trusted Customer TrustedCustomerGrp

FieldValueIRS element (for citing)
Trusted Customer2TrustedCustomerCd
FieldValueIRS element (for citing)
Tax2021TaxYr
Build TS2023-04-26 12:10:37ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Principal OfficerScott StaszakPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line1230 E Ohio Street Suite 500AddressLine1Txt
CityChicagoCityNm
State AbbreviationILStateAbbreviationCd
ZIP606113270ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$12,668,878GrossReceiptsAmt
Group Return For AffiliatesfalseGroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website Addresswww.pulmonaryfibrosis.orgWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation2000FormationYr
Legal Domicile StateCOLegalDomicileStateCd
Activity Or MissionTo mobilize people and resources to provide access to high-quality care and lead research for a cure so that people with pulmonary fibrosis will live longer, healthier lives.ActivityOrMissionDesc
Voting Members Governing Body13VotingMembersGoverningBodyCnt
Voting Members Independent13VotingMembersIndependentCnt
Total Employee41TotalEmployeeCnt
Total Volunteers2234TotalVolunteersCnt
Total Gross UBI$0TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$0NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$6,636,670PYContributionsGrantsAmt
CY Contributions Grants$8,774,899CYContributionsGrantsAmt
PY Program Service Revenue$2,908,697PYProgramServiceRevenueAmt
CY Program Service Revenue$2,545,747CYProgramServiceRevenueAmt
PY Investment Income$65,617PYInvestmentIncomeAmt
CY Investment Income$297,956CYInvestmentIncomeAmt
PY Other Revenue-$645,389PYOtherRevenueAmt
CY Other Revenue-$610,699CYOtherRevenueAmt
PY Total Revenue$8,965,595PYTotalRevenueAmt
CY Total Revenue$11,007,903CYTotalRevenueAmt
PY Grants And Similar Paid$302,895PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$319,696CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$3,807,101PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$4,143,847CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$0PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$1,139,704CYTotalFundraisingExpenseAmt
PY Other Expenses$4,231,849PYOtherExpensesAmt
CY Other Expenses$5,222,076CYOtherExpensesAmt
PY Total Expenses$8,341,845PYTotalExpensesAmt
CY Total Expenses$9,685,619CYTotalExpensesAmt
PY Revenues Less Expenses$623,750PYRevenuesLessExpensesAmt
CY Revenues Less Expenses$1,322,284CYRevenuesLessExpensesAmt
Total Assets BOY$14,745,592TotalAssetsBOYAmt
Total Assets EOY$17,064,469TotalAssetsEOYAmt
Total Liabilities BOY$5,433,309TotalLiabilitiesBOYAmt
Total Liabilities EOY$7,089,463TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$9,312,283NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$9,975,006NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionTO MOBILIZE PEOPLE AND RESOURCES TO PROVIDE ACCESS TO HIGH-QUALITY CARE AND LEAD RESEARCH FOR A CURE SO THAT PEOPLE WITH PULMONARY FIBROSIS WILL LIVE LONGER, HEALTHIER LIVES.MissionDesc
Significant New Program SrvcfalseSignificantNewProgramSrvcInd
Significant ChangefalseSignificantChangeInd
Expense$2,911,005ExpenseAmt
Grant$0GrantAmt
Revenue$2,210,840RevenueAmt
Desc1. PFF PATIENT REGISTRY: TOTAL REVENUE RECOGNIZED FOR THE PFF REGISTRY PROGRAM WAS $2,558,493, WHICH INCLUDED CONTRIBUTIONS AND SPONSORSHIPS OF $347,654 IN ADDITION TO THE PROGRAM SERVICE REVENUE OF $2,210,840. THE PROGRAM IS A RESEARCH EFFORT THAT BRINGS TOGETHER MULTIPLE STAKEHOLDERS INCLUDING PATIENTS, CAREGIVERS, FAMILY MEMBERS, HEALTH CARE PROVIDERS, AND RESEARCHERS TO ADVANCE RESEARCH AND IMPROVE THE QUALITY OF LIFE OF PATIENTS WITH PULMONARY FIBROSIS (PF) AND INTERSTITIAL LUNG DISEASE (ILD). THE REGISTRY'S SPECIFIC AIMS FOLLOW: (CONTINUED ON SCHEDULE O)Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Expense$622,259ExpenseAmt
Grant$0GrantAmt
Revenue$0RevenueAmt
Desc2. PFF CARE CENTER NETWORK: TOTAL REVENUE RECOGNIZED FOR THE CCN WAS $325,261, WHICH IS COMPRISED OF CONTRIBUTIONS AND SPONSORSHIPS. THE PULMONARY FIBROSIS FOUNDATION (PFF) IS DEDICATED TO PROMOTING EARLIER RECOGNITION AND DIAGNOSIS OF PULMONARY FIBROSIS AND ENSURING THAT PATIENTS RECEIVE THE HIGHEST QUALITY HEALTHCARE. AS PART OF THAT COMMITMENT, SINCE 2013 THE PFF HAS WORKED WITH THE PF MEDICAL COMMUNITY TO ESTABLISH AND EXPAND THE PFF CARE CENTER NETWORK (CCN) TO 74 CARE CENTERS WHERE PEOPLE WITH PF CAN FIND EXPERIENCED MEDICAL PROFESSIONALS (CONTINUED ON SCHEDULE O)Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

FieldValueIRS element (for citing)
Expense$616,137ExpenseAmt
Grant$0GrantAmt
Revenue$268,621RevenueAmt
Desc3. CORPORATE PARTNERSHIPS: Total revenue recognized for Corporate Partnerships was $462,931, which included contributions and sponsorships of $194,310 in addition to the program service revenue of $268,621. The Prognostic Lung Fibrosis Consortium (PROLIFIC) convened quarterly throughout the fiscal year to complete the statistical analysis plan for the biomarker analysis and approve the budget to begin testing. PROLIFIC is a consortium of companies and foundations developing tests to identify important markers for PF. Twelve initial biomarkers were selected (Continued on Schedule O)Desc
FieldValueIRS element (for citing)
Total Other Prog Srvc Expense$3,050,004TotalOtherProgSrvcExpenseAmt
Total Other Prog Srvc Grant$319,696TotalOtherProgSrvcGrantAmt
Total Other Prog Srvc Revenue$66,286TotalOtherProgSrvcRevenueAmt
Total Program Service Expenses$7,199,405TotalProgramServiceExpensesAmt
Described In Section501c3Yes (true)DescribedInSection501c3Ind
Schedule B RequiredYes (true)ScheduleBRequiredInd
Political Campaign ActyfalsePoliticalCampaignActyInd
Lobbying ActivitiesYes (true)LobbyingActivitiesInd
Subject To Proxy TaxfalseSubjectToProxyTaxInd
Donor Advised FundfalseDonorAdvisedFundInd
Conservation EasementsfalseConservationEasementsInd
Collections Of ArtfalseCollectionsOfArtInd
Credit CounselingfalseCreditCounselingInd
Donor Rstr Or Quasi EndowmentsfalseDonorRstrOrQuasiEndowmentsInd
Report Land Building EquipmentYes (true)ReportLandBuildingEquipmentInd
Report Investments Other SecfalseReportInvestmentsOtherSecInd
Report Program Related InvstYes (true)ReportProgramRelatedInvstInd
Report Other AssetsfalseReportOtherAssetsInd
Report Other LiabilitiesfalseReportOtherLiabilitiesInd
Include FIN48 FootnoteYes (true)IncludeFIN48FootnoteInd
Independent Audit Fincl StmtYes (true)IndependentAuditFinclStmtInd
Consolidated Audit Fincl StmtfalseConsolidatedAuditFinclStmtInd
School OperatingfalseSchoolOperatingInd
Foreign OfficefalseForeignOfficeInd
Foreign ActivitiesfalseForeignActivitiesInd
More Than5000 K To OrgfalseMoreThan5000KToOrgInd
More Than5000 K To IndividualsfalseMoreThan5000KToIndividualsInd
Professional FundraisingfalseProfessionalFundraisingInd
Fundraising ActivitiesYes (true)FundraisingActivitiesInd
Gaming ActivitiesfalseGamingActivitiesInd
Operate HospitalfalseOperateHospitalInd
Grants To OrganizationsYes (true)GrantsToOrganizationsInd
Grants To IndividualsfalseGrantsToIndividualsInd
Schedule J RequiredYes (true)ScheduleJRequiredInd
Tax Exempt BondsfalseTaxExemptBondsInd
Engaged In Excess Benefit TransfalseEngagedInExcessBenefitTransInd
PY Excess Benefit TransfalsePYExcessBenefitTransInd
Loan OutstandingfalseLoanOutstandingInd
Grant To Related PersonfalseGrantToRelatedPersonInd
Business Rln With Org MemfalseBusinessRlnWithOrgMemInd
Business Rln With Fam MemfalseBusinessRlnWithFamMemInd
Business Rln With35 Ctrl EntfalseBusinessRlnWith35CtrlEntInd
Deductible Non Cash ContriYes (true)DeductibleNonCashContriInd
Deductible Art ContributionfalseDeductibleArtContributionInd
Terminate OperationsfalseTerminateOperationsInd
Partial LiquidationfalsePartialLiquidationInd
Disregarded EntityfalseDisregardedEntityInd
Related EntityfalseRelatedEntityInd
Related Organization Ctrl EntfalseRelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd OrgfalseTrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted PrtshpfalseActivitiesConductedPrtshpInd
Schedule O RequiredYes (true)ScheduleORequiredInd
IRP Document30IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (true)BackupWthldComplianceInd
Employee41EmployeeCnt
Employment Tax Returns FiledYes (true)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over LimitfalseUnrelatedBusIncmOverLimitInd
Foreign Financial AccountfalseForeignFinancialAccountInd
Prohibited Tax Shelter TransfalseProhibitedTaxShelterTransInd
Taxable Party NotificationfalseTaxablePartyNotificationInd
Nondeductible ContributionsfalseNondeductibleContributionsInd
Quid Pro Quo ContributionsYes (true)QuidProQuoContributionsInd
Quid Pro Quo Contri DisclYes (true)QuidProQuoContriDisclInd
Form8282 Property Disposed OffalseForm8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft CntrctfalseRcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft CntrctfalsePayPremiumsPrsnlBnftCntrctInd
Indoor Tanning ServicesfalseIndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht PymtfalseSubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst IncfalseSubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members13GoverningBodyVotingMembersCnt
Independent Voting Member13IndependentVotingMemberCnt
Family Or Business RlnfalseFamilyOrBusinessRlnInd
Delegation Of Mgmt DutiesfalseDelegationOfMgmtDutiesInd
Change To Org DocumentsfalseChangeToOrgDocumentsInd
Material Diversion Or MisusefalseMaterialDiversionOrMisuseInd
Members Or StockholdersfalseMembersOrStockholdersInd
Election Of Board MembersfalseElectionOfBoardMembersInd
Decisions Subject To ApprovafalseDecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (true)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (true)MinutesOfCommitteesInd
Officer Mailing AddressfalseOfficerMailingAddressInd
Local ChaptersfalseLocalChaptersInd
Form990 Provided To Gvrn BodyYes (true)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (true)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (true)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (true)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (true)WhistleblowerPolicyInd
Document Retention PolicyYes (true)DocumentRetentionPolicyInd
Compensation Process CEOYes (true)CompensationProcessCEOInd
Compensation Process OtherYes (true)CompensationProcessOtherInd
Investment In Joint VenturefalseInvestmentInJointVentureInd
States Where Copy Of Return Is FldALStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldAKStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldARStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCOStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldDCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldFLStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldGAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldILStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMEStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNJStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldOKStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldORStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldPAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldRIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldSCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldTNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldUTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldVAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWVStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWIStatesWhereCopyOfReturnIsFldCd
Own WebsiteYes (X)OwnWebsiteInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

FieldValueIRS element (for citing)
PersonSCOTT STASZAK COOPersonNm
Phone3122652182PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1230 EAST OHIO STREET SUITE 500AddressLine1Txt
CityCHICAGOCityNm
State AbbreviationILStateAbbreviationCd
ZIP60611ZIPCd
FieldValueIRS element (for citing)
Info In Schedule O Part VIIYes (X)InfoInScheduleOPartVIIInd

Form990 Part VII Section A Form990PartVIISectionAGrp (22 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtAverage Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRtOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtKey EmployeeKeyEmployeeIndHighest Compensated EmployeeHighestCompensatedEmployeeIndIndividual Trustee Or DirectorIndividualTrusteeOrDirectorInd
William T Schmidt
Director/President and CEO40.00.0Yes (X)$421,968$0$12,793
Scott Staszak
Chief Operating Officer40.00.0Yes (X)$313,854$0$12,217
Laura Sadler
Chief Marketing Officer40.00.0$189,524$0$28,935Yes (X)
Seth Klein
Senior VP, Development40.00.0$177,121$0$7,972Yes (X)
Junelle Speller
VP, PFF Registry40.00.0$164,480$0$6,573Yes (X)
Jessica Shore
VP, Research & Programs40.00.0$157,800$0$5,474Yes (X)
Kate Gates
VP, Advocacy & Programs40.00.0$133,437$0$23,807Yes (X)
Janet Bianchetta
VP, Finance40.00.0$140,557$0$13,621Yes (X)
DAVID MCNINCH
INTERIM CHAIR1.00.0Yes (X)$0$0$0Yes (X)
LAURIE CHANDLER CFP
Interim Vice Chair/Treasurer1.00.0Yes (X)$0$0$0Yes (X)
TERENCE HALES
SECRETARY1.00.0Yes (X)$0$0$0Yes (X)
MARTIN ATTWELL
MEMBER1.00.0$0$0$0Yes (X)
GEORGE ELIADES
MEMBER1.00.0$0$0$0Yes (X)
JULIE HALSTON
MEMBER1.00.0$0$0$0Yes (X)
Jeff Harris
MEMBER1.00.0$0$0$0Yes (X)
Mike Henderson
MEMBER (thru 11/21)1.00.0$0$0$0Yes (X)
Susan Jacobs
MEMBER1.00.0$0$0$0Yes (X)
HEATHER KAGEL
MEMBER1.00.0$0$0$0Yes (X)
PJ KAMANI
MEMBER1.00.0$0$0$0Yes (X)
ANDY LIMPER
MEMBER1.00.0$0$0$0Yes (X)
BARBARA MURPHY
MEMBER1.00.0$0$0$0Yes (X)
Patricia Rosa
MEMBER1.00.0$0$0$0Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$1,698,741TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$111,392TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K13IndivRcvdGreaterThan100KCnt
Former Ofcr Employees ListedfalseFormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (true)TotalCompGreaterThan150KInd
Compensation From Other SrcsfalseCompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (2 entries)

Address Line1ContractorAddress/USAddress/AddressLine1TxtCityContractorAddress/USAddress/CityNmState AbbreviationContractorAddress/USAddress/StateAbbreviationCdZIPContractorAddress/USAddress/ZIPCdServicesServicesDescCompensationCompensationAmt
Dorothy Coyle Raclaw
5855 N Kenneth AveCHICAGOIL60646Marketing Consulting$150,345
JUDAH VIOLA
4711 N WHIPPLE STCHICAGOIL60625PROGRAM CONSULTING$119,400
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K2CntrctRcvdGreaterThan100KCnt
Fundraising$1,390,980FundraisingAmt
All Other Contributions$7,383,919AllOtherContributionsAmt
Noncash Contributions$2,432,097NoncashContributionsAmt
Total Contributions$8,774,899TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp (4 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtRelated Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt
REGISTRY SPECIFIC900099$2,210,840$2,210,840
CORP PARTNERSHIPS900099$268,621$268,621
PFF SUMMIT900099$65,661$65,661
ADVOCACY LEGISLATIVE900099$625$625
FieldValueIRS element (for citing)
Total Program Service Revenue$2,545,747TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$233,512TotalRevenueColumnAmt
Exclusion$233,512ExclusionAmt

Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Royalties Revenue RoyaltiesRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Rental Income Or Loss RentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Real$0RealAmt
Personal$0PersonalAmt

Net Rental Income Or Loss NetRentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$1,059,855SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$995,411SecuritiesAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities$64,444SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column$64,444TotalRevenueColumnAmt
Exclusion$64,444ExclusionAmt
FieldValueIRS element (for citing)
Fundraising Gross Income$44,550FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event$1,390,980ContriRptFundraisingEventAmt
Fundraising Direct Expenses$658,147FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

FieldValueIRS element (for citing)
Total Revenue Column-$613,597TotalRevenueColumnAmt
Exclusion-$613,597ExclusionAmt
FieldValueIRS element (for citing)
Gaming Gross Income$0GamingGrossIncomeAmt
Gaming Direct Expenses$0GamingDirectExpensesAmt

Net Income From Gaming NetIncomeFromGamingGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
FieldValueIRS element (for citing)
Gross Sales Of Inventory$9,815GrossSalesOfInventoryAmt
Cost Of Goods Sold$7,417CostOfGoodsSoldAmt

Net Income Or Loss NetIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column$2,398TotalRevenueColumnAmt
Exclusion$2,398ExclusionAmt

Other Revenue Misc OtherRevenueMiscGrp

FieldValueIRS element (for citing)
DescUBIT REFUNDDesc
Business900099BusinessCd
Total Revenue Column$500TotalRevenueColumnAmt
Exclusion$500ExclusionAmt
FieldValueIRS element (for citing)
Other Revenue Total$500OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$11,007,903TotalRevenueColumnAmt
Related Or Exempt Func Income$2,545,747RelatedOrExemptFuncIncomeAmt
Exclusion-$312,743ExclusionAmt
FieldValueIRS element (for citing)
Info In Schedule O Part IXYes (X)InfoInScheduleOPartIXInd

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$319,696TotalAmt
Program Services$319,696ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Foreign Grants ForeignGrantsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Benefits To Members BenefitsToMembersGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$887,126TotalAmt
Program Services$539,607ProgramServicesAmt
Management And General$117,941ManagementAndGeneralAmt
Fundraising$229,578FundraisingAmt

Comp Disqual Persons CompDisqualPersonsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$2,801,204TotalAmt
Program Services$1,615,999ProgramServicesAmt
Management And General$628,850ManagementAndGeneralAmt
Fundraising$556,355FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$64,790TotalAmt
Program Services$35,811ProgramServicesAmt
Management And General$16,101ManagementAndGeneralAmt
Fundraising$12,878FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$177,458TotalAmt
Program Services$86,576ProgramServicesAmt
Management And General$51,770ManagementAndGeneralAmt
Fundraising$39,112FundraisingAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$213,269TotalAmt
Program Services$114,578ProgramServicesAmt
Management And General$56,043ManagementAndGeneralAmt
Fundraising$42,648FundraisingAmt

Fees For Services Management FeesForServicesManagementGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$32,800TotalAmt
Management And General$32,800ManagementAndGeneralAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$53,065TotalAmt
Management And General$53,065ManagementAndGeneralAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

FieldValueIRS element (for citing)
Total$232,675TotalAmt
Program Services$232,675ProgramServicesAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

FieldValueIRS element (for citing)
Total$0TotalAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$29,861TotalAmt
Management And General$29,861ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$3,741,524TotalAmt
Program Services$3,426,207ProgramServicesAmt
Management And General$245,121ManagementAndGeneralAmt
Fundraising$70,196FundraisingAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$118,689TotalAmt
Program Services$113,058ProgramServicesAmt
Management And General$1,963ManagementAndGeneralAmt
Fundraising$3,668FundraisingAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$212,317TotalAmt
Program Services$145,401ProgramServicesAmt
Management And General$17,517ManagementAndGeneralAmt
Fundraising$49,399FundraisingAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$16,437TotalAmt
Program Services$9,972ProgramServicesAmt
Management And General$3,147ManagementAndGeneralAmt
Fundraising$3,318FundraisingAmt

Royalties RoyaltiesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$227,073TotalAmt
Program Services$137,678ProgramServicesAmt
Management And General$43,484ManagementAndGeneralAmt
Fundraising$45,911FundraisingAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$43,026TotalAmt
Program Services$32,305ProgramServicesAmt
Management And General$8,779ManagementAndGeneralAmt
Fundraising$1,942FundraisingAmt

Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$8,487TotalAmt
Program Services$7,645ProgramServicesAmt
Management And General$412ManagementAndGeneralAmt
Fundraising$430FundraisingAmt

Interest InterestGrp

FieldValueIRS element (for citing)
Total$3TotalAmt
Management And General$3ManagementAndGeneralAmt

Payments To Affiliates PaymentsToAffiliatesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$98,114TotalAmt
Program Services$90,968ProgramServicesAmt
Management And General$3,237ManagementAndGeneralAmt
Fundraising$3,909FundraisingAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$49,440TotalAmt
Program Services$28,837ProgramServicesAmt
Management And General$10,959ManagementAndGeneralAmt
Fundraising$9,644FundraisingAmt

Other Expenses OtherExpensesGrp (3 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmtFundraisingFundraisingAmt
SOFTWARE SUBSCRIPTIONS-SAAS$207,032$129,390$16,706$60,936
EVENT EXPENSE$122,115$111,236$1,120$9,759
DUES/SUBSCRIPTIONS/REGISTRAT$29,418$21,766$7,631$21

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$9,685,619TotalAmt
Program Services$7,199,405ProgramServicesAmt
Management And General$1,346,510ManagementAndGeneralAmt
Fundraising$1,139,704FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$537,465BOYAmt
EOY$1,111,860EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$5,853,121BOYAmt
EOY$5,356,166EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$58,296BOYAmt
EOY$204,965EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$1,503,472BOYAmt
EOY$2,586,813EOYAmt

Receivables From Officers Etc ReceivablesFromOfficersEtcGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Inventories For Sale Or Use InventoriesForSaleOrUseGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$507,279BOYAmt
EOY$552,239EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$270,819LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$197,541LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$45,371BOYAmt
EOY$73,278EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$5,549,485BOYAmt
EOY$6,557,385EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Investments Program Related InvestmentsProgramRelatedGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Intangible Assets IntangibleAssetsGrp

FieldValueIRS element (for citing)
BOY$259,472BOYAmt
EOY$190,132EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$431,631BOYAmt
EOY$431,631EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$14,745,592BOYAmt
EOY$17,064,469EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$2,077,344BOYAmt
EOY$2,221,067EOYAmt

Grants Payable GrantsPayableGrp

FieldValueIRS element (for citing)
BOY$337,500BOYAmt
EOY$350,000EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$2,437,790BOYAmt
EOY$3,937,721EOYAmt

Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Escrow Account Liability EscrowAccountLiabilityGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Loans From Officers Directors LoansFromOfficersDirectorsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp

FieldValueIRS element (for citing)
BOY$580,675BOYAmt
EOY$580,675EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$5,433,309BOYAmt
EOY$7,089,463EOYAmt
FieldValueIRS element (for citing)
Organization Follows FASB117Yes (X)OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$6,584,930BOYAmt
EOY$6,338,585EOYAmt

Donor Restriction Net Assets DonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$2,727,353BOYAmt
EOY$3,636,421EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$9,312,283BOYAmt
EOY$9,975,006EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$14,745,592BOYAmt
EOY$17,064,469EOYAmt
FieldValueIRS element (for citing)
Reconcilation Revenue Expnss$1,322,284ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst-$659,561NetUnrlzdGainsLossesInvstAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or ReviewfalseAccountantCompileOrReviewInd
FS AuditedYes (true)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Separate Basis Fincl StmtYes (X)SeparateBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (true)AuditCommitteeInd
Federal Grant Audit RequiredfalseFederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$5,989,047CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$8,449,631CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$8,450,064CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$6,636,670CurrentTaxYearMinus1YearAmt
Current Tax Year$8,774,899CurrentTaxYearAmt
Total$38,300,311TotalAmt

Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$5,989,047CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$8,449,631CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$8,450,064CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$6,636,670CurrentTaxYearMinus1YearAmt
Current Tax Year$8,774,899CurrentTaxYearAmt
Total$38,300,311TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$12,699,358SubstantialContributorsTotAmt
Public Support Total170$25,600,953PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$69,969CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$273,967CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$257,033CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$152,919CurrentTaxYearMinus1YearAmt
Current Tax Year$233,512CurrentTaxYearAmt
Total$987,400TotalAmt

Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Other Income170 OtherIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$691CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$234CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$2CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$12,865CurrentTaxYearMinus1YearAmt
Current Tax Year$500CurrentTaxYearAmt
Total$14,292TotalAmt
FieldValueIRS element (for citing)
Total Support$39,302,003TotalSupportAmt
Gross Receipts Rltd Activities$13,177,422GrossReceiptsRltdActivitiesAmt
Public Support CY1700.65139PublicSupportCY170Pct
Public Support PY1700.59949PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule C IRS990ScheduleC

Total Grassroots Lobbying TotalGrassrootsLobbyingGrp

FieldValueIRS element (for citing)
Filing Organizations Total$39,596FilingOrganizationsTotalAmt

Total Direct Lobbying TotalDirectLobbyingGrp

FieldValueIRS element (for citing)
Filing Organizations Total$193,079FilingOrganizationsTotalAmt

Total Lobbying Expend TotalLobbyingExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$232,675FilingOrganizationsTotalAmt

Other Exempt Purpose Expend OtherExemptPurposeExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$6,966,730FilingOrganizationsTotalAmt

Total Exempt Purpose Expend TotalExemptPurposeExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$7,199,405FilingOrganizationsTotalAmt

Lobbying Nontaxable Amount LobbyingNontaxableAmountGrp

FieldValueIRS element (for citing)
Filing Organizations Total$509,970FilingOrganizationsTotalAmt

Grassroots Nontaxable GrassrootsNontaxableGrp

FieldValueIRS element (for citing)
Filing Organizations Total$127,493FilingOrganizationsTotalAmt
FieldValueIRS element (for citing)
Tot Lbbyng Grassroot Mns Non TxTotLbbyngGrassrootMnsNonTxGrp
Tot Lbby Expend Mns Lbbyng Non TxTotLbbyExpendMnsLbbyngNonTxGrp

Avg Lobbying Nontaxable Amount AvgLobbyingNontaxableAmountGrp

FieldValueIRS element (for citing)
Current Year Minus3$466,993CurrentYearMinus3Amt
Current Year Minus2$602,580CurrentYearMinus2Amt
Current Year Minus1$449,439CurrentYearMinus1Amt
Current Year$509,970CurrentYearAmt
Total$2,028,982TotalAmt
FieldValueIRS element (for citing)
Lobbying Ceiling$3,043,473LobbyingCeilingAmt

Avg Total Lobbying Expend AvgTotalLobbyingExpendGrp

FieldValueIRS element (for citing)
Current Year Minus3$79,435CurrentYearMinus3Amt
Current Year Minus2$280,017CurrentYearMinus2Amt
Current Year Minus1$198,655CurrentYearMinus1Amt
Current Year$232,675CurrentYearAmt
Total$790,782TotalAmt

Avg Grassroots Nontaxable AvgGrassrootsNontaxableGrp

FieldValueIRS element (for citing)
Current Year Minus3$116,748CurrentYearMinus3Amt
Current Year Minus2$150,645CurrentYearMinus2Amt
Current Year Minus1$112,360CurrentYearMinus1Amt
Current Year$127,493CurrentYearAmt
Total$507,246TotalAmt
FieldValueIRS element (for citing)
Grassroots Ceiling$760,869GrassrootsCeilingAmt

Avg Grassroots Lobbying Expend AvgGrassrootsLobbyingExpendGrp

FieldValueIRS element (for citing)
Current Year Minus3$58,081CurrentYearMinus3Amt
Current Year Minus2$40,551CurrentYearMinus2Amt
Current Year Minus1$37,091CurrentYearMinus1Amt
Current Year$39,596CurrentYearAmt
Total$175,319TotalAmt

Schedule D IRS990ScheduleD

FieldValueIRS element (for citing)
Art Public Exhibition AmountsArtPublicExhibitionAmountsGrp
Held Works ArtHeldWorksArtGrp
CY Minus3 Yr Endwmt FundCYMinus3YrEndwmtFundGrp
CY Minus4 Yr Endwmt FundCYMinus4YrEndwmtFundGrp
LandLandGrp
BuildingsBuildingsGrp
Leasehold ImprovementsLeaseholdImprovementsGrp

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$188,694OtherCostOrOtherBasisAmt
Depreciation$127,378DepreciationAmt
Book Value$61,316BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$82,125OtherCostOrOtherBasisAmt
Depreciation$70,163DepreciationAmt
Book Value$11,962BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$73,278TotalBookValueLandBuildingsAmt
Federal Income Tax Liability$0FederalIncomeTaxLiabilityAmt
Total Liability$0TotalLiabilityAmt
Footnote TextYes (X)FootnoteTextInd
Total Rev Etc Audited Fincl Stmt$11,013,906TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst-$659,561NetUnrealizedGainsInvstAmt
Revenue Not Reported-$659,561RevenueNotReportedAmt
Revenue Subtotal$11,673,467RevenueSubtotalAmt
Other Revenues Not Included-$665,564OtherRevenuesNotIncludedAmt
Revenue Not Reported Fincl Stmt-$665,564RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$11,007,903TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$10,351,183TotExpnsEtcAuditedFinclStmtAmt
Other Expenses Included$665,564OtherExpensesIncludedAmt
Expenses Not Reported$665,564ExpensesNotReportedAmt
Expenses Subtotal$9,685,619ExpensesSubtotalAmt
Total Expenses Per Form990$9,685,619TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
SCHEDULE D, PART X, LINE 2:THE ORGANIZATION IS EXEMPT FROM INCOME TAXES UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE ("IRC"), EXCEPT FOR NET INCOME DERIVED FROM UNRELATED BUSINESS ACTIVITIES. IN ADDITION, THE ORGANIZATION QUALIFIES FOR THE CHARITABLE CONTRIBUTION DEDUCTION UNDER SECTION 170(B)(1)(A) AND HAS BEEN CLASSIFIED AS AN ORGANIZATION OTHER THAN A PRIVATE FOUNDATION UNDER IRC SECTION 509(A). THE ORGANIZATION'S INCOME TAX FILINGS ARE SUBJECT TO AUDIT BY VARIOUS TAXING AUTHORITIES. IN EVALUATING THE ORGANIZATION'S ACTIVITIES, MANAGEMENT BELIEVES ITS POSITION OF TAX-EXEMPT STATUS IS BASED ON CURRENT FACTS AND CIRCUMSTANCES AND THERE HAVE BEEN NO UNCERTAIN POSITIONS TAKEN RELATED TO RECORDING INCOME TAXES. IT IS THE POLICY OF THE ORGANIZATION TO INCLUDE IN MANAGEMENT AND GENERAL EXPENSES PENALTIES AND INTEREST ASSESSED BY INCOME TAXING AUTHORITIES. THERE WERE PENALTIES OF $38 AND INTEREST OF $285 FROM TAXING AUTHORITIES INCLUDED IN MANAGEMENT AND GENERAL EXPENSES FOR THE YEAR ENDED JUNE 30, 2022.
Schedule D, Part XI, Line 4b - Other AdjustmentsSpecial Events: ($ 658,147) SALE OF GOODS: ($ 7,417) Total: ($ 665,564)
Schedule D, Part XII, Line 2d - Other AdjustmentsSpecial Events: $658,147 SALE OF GOODS: $7,417 Total: $665,564

Schedule G IRS990ScheduleG

Fundraising Event Information FundraisingEventInformationGrp

FieldValueIRS element (for citing)
Event1PFF WALKSEvent1Nm
Gross Receipts Event1$950,186GrossReceiptsEvent1Amt
Charitable Contri Event1$950,186CharitableContriEvent1Amt
Entertainment Event1$100EntertainmentEvent1Amt
Other Direct Expenses Event1$341,428OtherDirectExpensesEvent1Amt
Event2BROADWAY BELTSEvent2Nm
Gross Receipts Event2$485,344GrossReceiptsEvent2Amt
Charitable Contri Event2$440,794CharitableContriEvent2Amt
Gross Revenue Event2$44,550GrossRevenueEvent2Amt
Food And Beverage Event2$79,759FoodAndBeverageEvent2Amt
Entertainment Event2$350EntertainmentEvent2Amt
Other Direct Expenses Event2$236,510OtherDirectExpensesEvent2Amt
Other Events Total0OtherEventsTotalCnt
Gross Receipts Total$1,435,530GrossReceiptsTotalAmt
Charitable Contributions Tot$1,390,980CharitableContributionsTotAmt
Gross Revenue Total Events$44,550GrossRevenueTotalEventsAmt
Food And Beverage Total Events$79,759FoodAndBeverageTotalEventsAmt
Entertainment Total Events$450EntertainmentTotalEventsAmt
Oth Direct Expnss Total Events$577,938OthDirectExpnssTotalEventsAmt
Direct Expense Summary Events$658,147DirectExpenseSummaryEventsAmt
Net Income Summary-$613,597NetIncomeSummaryAmt

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (true)GrantRecordsMaintainedInd

Recipient Table RecipientTable (4 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINIRC SectionIRCSectionDescCash GrantCashGrantAmtPurpose Of GrantPurposeOfGrantTxt
Virginia Commonwealth University
800 East Leigh Street Box 980568RichmondVA23298540757884501(c)(3)$75,000See Part IV
University of California San Francisco
1855 Folsom St 425San FranciscoCA94143946036493501(c)(3)$75,000See Part IV
National Jewish Health
1400 Jackson St Room A368DenverCO80206742044647501(c)(3)$75,000See Part IV
Virginia Commonwealth University
800 East Leigh StREETRichmondVA23298540757884501(c)(3)$75,000See Part IV
FieldValueIRS element (for citing)
Total501c3 Org4Total501c3OrgCnt

Supplemental Information Detail SupplementalInformationDetail (5 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Schedule I, Part I, Line 2FOR LARGER GRANTS, THE ORGANIZATION REQUESTS SEMI-ANNUAL REPORTS DETAILING THE USE OF GRANT FUNDS FROM THE RECIPIENT ORGANIZATIONS.
Schedule I, Part II, Line 1(h) Purpose of Grant1. VIRGINIA COMMONWEALTH UNIVERSITY "INVESTIGATION OF SEROLOGIC AND PULMONARY MEDIATORS OF POST-TUBERCULOSIS LUNG FIBROSIS IN A UGANDAN COHORT" TUBERCULOSIS IS AN ONGOING PANDEMIC WITH OVER 10 MILLION CASES AND 1.2 MILLION DEATHS ANNUALLY. IN THOSE THAT SURVIVE ACUTE TB UP TO 50% WILL DEVELOP POST-TB LUNG IMPAIRMENT (PTLI) RESULTING IN ONGOING SYMPTOMS, AND DISABILITY. WITH OVER 90% OF TB CASES OCCURRING IN LOW-MIDDLE-INCOME COUNTRIES, PTLI OFTEN RESULTS IN FOOD INSECURITY, WORSE SOCIOECONOMIC STATUS, AND INCREASED MORTALITY FROM SECONDARY CAUSES. DESPITE THE LARGE BURDEN OF PTLI THERE IS LIMITED RESEARCH ON THE DISORDER. IT IS POSTULATED THAT COMPLEX INTERACTIONS BETWEEN THE BACTERIA THAT CAUSE TB AND THE PATIENT'S IMMUNE SYSTEM RESULTS IN SCARRING AND LONG-LASTING LUNG IMPAIRMENT. WHILE THERE HAVE BEEN SOME STUDIES EVALUATING THIS LINK THERE IS NO CONSENSUS ON THE PATHWAYS INVOLVED OR HOW TO TREAT PATIENTS TO PREVENT THIS LUNG DAMAGE. OUR STUDY WILL BE THE FIRST OF ITS KIND, TO NOT ONLY DETERMINE CLINICAL RISK FACTORS FOR PTLI DEVELOPMENT, BUT ALSO TO LONGITUDINALLY EVALUATE THE IMMUNOLOGIC PATHWAYS THAT CAUSE THIS DISORDER. WE WILL ANALYZE INFLAMMATORY CYTOKINES AND REGULATORY LIPIDS IN THE BLOOD AND LUNG TO IDENTIFY THE CAUSE OF PTLI AND DISCOVER TARGETS FOR THERAPIES THAT CAN PREVENT THIS DEVASTATING DISEASE.
Schedule I, Part II, Line 2(h) Purpose of Grant2. UNIVERSITY OF CALIFORNIA, SAN FRANCISCO "DISPARITIES IN ANTIFIBROTIC UTILIZATION AMONG VETERANS: UNDERSTANDING THE ACCESS GAP" THE PURPOSE OF THIS APPLICATION IS TO IMPROVE OUTCOMES FOR PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF). PRIOR WORK IDENTIFIED A NATIONAL COHORT OF 123,000 U.S. VETERANS DIAGNOSED WITH IPF BETWEEN 2014 - 2019 AND FOUND THAT LESS THAN 5% OF THESE VETERANS WERE PRESCRIBED ANTIFIBROTICS. UTILIZATION WAS DISPROPORTIONATELY LOW AMONG FEMALE, BLACK, AND RURAL PATIENTS WITH VARIABILITY IN PRACTICE PATTERNS ACROSS VETERANS AFFAIRS HEALTHCARE SYSTEM FACILITIES. THIS PROPOSAL IS TO EXPLORE THE REASONS FOR THESE DISPARITIES AND IDENTIFY WAYS TO ADDRESS THEM. THE LONG-TERM GOAL IS TO DEVELOP NEW CARE DELIVERY STRATEGIES TO BRIDGE ACCESS GAPS AND IMPROVE OUTCOMES FOR PATIENTS WITH IPF.
Schedule I, Part II, Line 3(h) Purpose of Grant3. NATIONAL JEWISH HEALTH "A MULTIDIMENSIONAL RISK PREDICTION MODEL FOR PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASE" AMONG THE SPECTRUM OF FIBROSING INTERSTITIAL LUNG DISEASES (ILDS), PATIENTS WITH THE PROGRESSIVE FIBROSING PHENOTYPE (PF-ILD) DEMONSTRATE PROGRESSION, DESPITE MAXIMAL CONVENTIONAL TREATMENT. THERE IS NOW COMPELLING EVIDENCE THAT ANTIFIBROTIC THERAPY SLOWS THE RATE OF DISEASE PROGRESSION. WITH THE RECOGNITION OF THIS TREATMENT BENEFIT, THERE IS AN URGENT UNMET NEED FOR IMPROVED METHODS TO IDENTIFY PF-ILD PATIENTS TO ENSURE TIMELY INITIATION OF TREATMENT WITH THE GOAL OF IMPROVING LONG TERM OUTCOMES. THERE IS A CLEAR NEED FOR TOOLS TO PREDICT WHICH PATIENTS WILL DEVELOP PF-ILD AT DIAGNOSIS. CURRENT PREDICTOR MODELS RELY ON CLINICAL VARIABLES AND PULMONARY FUNCTION TO PREDICT MORTALITY IN IPF, BUT THEY DO NOT RELIABLY PREDICT DISEASE PROGRESSION. QUALITATIVE AND QUANTITATIVE IMAGING DATA PROVIDES COMPLEMENTARY INFORMATION THAT MAY IMPROVE DISEASE STAGING AND OUTCOME PREDICTION IN PF-ILD. THIS PROPOSAL IS A RISK PREDICTION MODEL USING DEMOGRAPHIC, CLINICAL, AND PHYSIOLOGICAL MARKERS IN COMBINATION WITH VISUAL AND MACHINE LEARNING TECHNIQUES ON BASELINE CT SCANS OF PATIENTS WITH PULMONARY FIBROSIS WILL HELP IDENTIFY AND RISK STRATIFY INDIVIDUALS WITH PROGRESSIVE FIBROSIS.
Schedule I, Part II, Line 4(h) Purpose of Grant4. VIRGINIA COMMONWEALTH UNIVERSITY - "TARGETING MECHANO-SENSORS AND ALTERED METABOLISM IN LUNG FIBROSIS" IDIOPATHIC PULMONARY FIBROSIS IS A PROGRESSIVE SCARRING DISEASE OF THE LUNG DRIVEN BY MULTIPLE OVERLAPPING DISEASE-CAUSING PROCESSES. MOST CURRENT RESEARCH FOCUSES ON TREATING SINGLE PATHWAYS, RESULTING IN CHALLENGES AND FAILURE WHEN TRANSLATED FROM THE LAB TO CLINICAL TRIALS. THIS PROPOSAL WILL INVESTIGATE A RECENTLY IDENTIFIED OVERLAP OF TWO PREVIOUSLY PRESUMED INDEPENDENT PROCESSES THAT PROMOTE FIBROSIS; TISSUE STIFFNESS AND ENERGY METABOLISM BY LUNG CELLS. THE STUDY HAS IDENTIFIED A PROBABLE CELL RECEPTOR INVOLVED WITH THESE PROCESSES THAT HAS POTENTIAL TO BE DEVELOPED INTO A THERAPY THAT TARGETS THESE MULTIPLE DISEASE PATHWAYS AT THE SAME TIME. THE LONG-TERM GOAL IS TO IDENTIFY A CO-TARGETING TREATMENT OPTION THAT WILL MORE EFFECTIVELY BLOCK THE PROGRESSION OF FIBROSIS COMPARED TO CURRENT ANTI-FIBROTIC MONOTHERAPIES.

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Compensation CommitteeYes (X)CompensationCommitteeInd
Independent ConsultantYes (X)IndependentConsultantInd
Form990 Of Other OrganizationsYes (X)Form990OfOtherOrganizationsInd
Written Employment ContractYes (X)WrittenEmploymentContractInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance PaymentfalseSeverancePaymentInd
Supplemental Nonqual Rtr PlanfalseSupplementalNonqualRtrPlanInd
Equity Based Comp ArrngmfalseEquityBasedCompArrngmInd
Comp Based On Revenue Of Flng OrgfalseCompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related OrgsfalseCompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng OrgfalseCompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd OrgsfalseCompBsdNetEarnsRltdOrgsInd
Any Non Fixed PaymentsfalseAnyNonFixedPaymentsInd
Initial Contract ExceptionfalseInitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (9 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
William T Schmidt
Director/President and CEO$291,655$0$115,000$0$15,313$0$12,263$0$530$0$434,761$0$0$0
Scott Staszak
Chief Operating Officer$242,784$0$71,070$0$0$0$11,687$0$530$0$326,071$0$0$0
Laura Sadler
Chief Marketing Officer$189,024$0$500$0$0$0$8,298$0$20,637$0$218,459$0$0$0
Seth Klein
Senior VP, Development$175,621$0$1,500$0$0$0$7,442$0$530$0$185,093$0$0$0
Junelle Speller
VP, PFF Registry$163,980$0$500$0$0$0$6,043$0$530$0$171,053$0$0$0
Jessica Shore
VP, Research & Programs$157,300$0$500$0$0$0$4,944$0$530$0$163,274$0$0$0
Jennifer Mefford
VP, Corporate Partnerships$134,791$0$500$0$0$0$5,744$0$12,638$0$153,673$0$0$0
Janet Bianchetta
VP, Finance$140,057$0$500$0$0$0$5,662$0$7,959$0$154,178$0$0$0
Kate Gates
VP, Advocacy & Programs$132,937$0$500$0$0$0$5,513$0$18,294$0$157,244$0$0$0

Schedule M IRS990ScheduleM

FieldValueIRS element (for citing)
Works Of ArtWorksOfArtGrp
Art Historical TreasuresArtHistoricalTreasuresGrp
Art Fractional InterestArtFractionalInterestGrp
Books And PublicationsBooksAndPublicationsGrp
Clothing And Household GoodsClothingAndHouseholdGoodsGrp
Cars And Other VehiclesCarsAndOtherVehiclesGrp
Boats And PlanesBoatsAndPlanesGrp
Intellectual PropertyIntellectualPropertyGrp

Securities Publicly Traded SecuritiesPubliclyTradedGrp

FieldValueIRS element (for citing)
Non Cash CheckboxYes (X)NonCashCheckboxInd
Contribution14ContributionCnt
Noncash Contributions Rpt F990$2,432,097NoncashContributionsRptF990Amt
Method Of Determining RevenuesFMVMethodOfDeterminingRevenuesTxt
FieldValueIRS element (for citing)
Securities Closely Held StockSecuritiesCloselyHeldStockGrp
Secur Prtnrshp Trust IntrstsSecurPrtnrshpTrustIntrstsGrp
Securities MiscellaneousSecuritiesMiscellaneousGrp
Qualified Contrib Hist StructQualifiedContribHistStructGrp
Qualified Contrib OtherQualifiedContribOtherGrp
Real Estate ResidentialRealEstateResidentialGrp
Real Estate CommercialRealEstateCommercialGrp
Real Estate OtherRealEstateOtherGrp
CollectiblesCollectiblesGrp
Food InventoryFoodInventoryGrp
Drugs And Medical SuppliesDrugsAndMedicalSuppliesGrp
TaxidermyTaxidermyGrp
Historical ArtifactsHistoricalArtifactsGrp
Scientific SpecimensScientificSpecimensGrp
Archaeological ArtifactsArchaeologicalArtifactsGrp
Any Property That Must Be HeldfalseAnyPropertyThatMustBeHeldInd
Review Process Unusual NC GiftsYes (true)ReviewProcessUnusualNCGiftsInd
Third Parties UsedfalseThirdPartiesUsedInd

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (30 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
CONTINUED FROM FORM 990, PART III, LINE 4A:. CREATE A ROBUST SOURCE OF INFORMATION TO HELP RESEARCHERS FIND ANSWERS TO BETTER DIAGNOSE, TREAT, AND POTENTIALLY FIND A CURE. . PROVIDE DATA SET TO HELP RESEARCHERS IMPROVE THE QUALITY OF CARE PROVIDED IN US-BASED MEDICAL PRACTICES. . UTILIZE INFORMATION TO SUPPORT LEGISLATIVE AND OTHER ADVOCACY EFFORTS. . ENGAGE AND ENERGIZE THE PF AND ILD COMMUNITY. THE PROGRAM INCLUDES TWO REGISTRIES: . FROM 2016 TO 2022, THE PFF PATIENT REGISTRY HAS COLLECTED PHYSICIAN-REPORTED MEDICAL INFORMATION EVERY SIX MONTHS FROM MORE 2003 PATIENTS WHO OBTAIN CARE AT 42 PARTICIPATING PFF CARE CENTERS ACROSS THE UNITED STATES. . LAUNCHED IN JULY 2022, THE PFF COMMUNITY REGISTRY RELIES ON SELF-REPORTED INFORMATION SUBMITTED BY PATIENTS AND LUNG TRANSPLANT RECIPIENTS WHO HAVE BEEN DIAGNOSED WITH PF OR ILD, AS WELL AS THEIR CAREGIVERS AND BIOLOGICAL FAMILY MEMBERS. COMBINED, THESE REGISTRIES CAPTURE INFORMATION IN AN ELECTRONIC DATABASE ON PATIENT DIAGNOSIS, MEDICAL HISTORY, TREATMENT, AND QUALITY OF LIFE AS WELL AS MEDICAL AND FAMILY HISTORY FROM CAREGIVERS AND FAMILY MEMBERS. DATA ARE MADE ANONYMOUS AND INDEPENDENTLY MANAGED BY A DATA COORDINATING CENTER. IN ADDITION, THE PATIENT REGISTRY COLLECTED BLOOD SAMPLES WITH PATIENT CONSENT. SAMPLES WERE THEN ANONYMIZED AND INDEPENDENTLY MANAGED BY A MEDICAL SPECIMEN STORAGE FACILITY ASSOCIATED WITH THE DATA COORDINATING CENTER. TO LEARN MORE ABOUT THE PFF REGISTRY, VISIT: PFFREGISTRY.ORG.
CONTINUED FROM FORM 990, PART III, LINE 4B:WHO UNDERSTAND THEIR DISEASE AND SUPPORT SERVICES TO IMPROVE THE QUALITY OF THEIR LIVES. THE GOALS OF THE PFF CCN ARE TO DELIVER STATE OF THE ART, PATIENT-CENTERED CARE; TO DISSEMINATE EDUCATION TO SUPPORT OUR PATIENTS, CAREGIVERS AND PROVIDERS; TO GIVE VOICE TO THE NEEDS OF OUR COMMUNITY THROUGH ADVOCACY AND FUNDRAISING; AND TO ACCELERATE RESEARCH IN PF BOTH DIRECTLY AND THROUGH COLLABORATIONS AND NETWORKING.
CONTINUED FROM 990, PART III, LINE 4C:for their potential to predict disease course of PF and to assess how well a drug will work in a specific individual. Findings will be used to inform and compare results across different clinical trials to expedite regulatory approval of new drugs. PFF partnered with a continuing medical education (CME) company to create "PFF Conference Highlights: News You Can Use," a CME series that provided comprehensive conference coverage with expert clinicians and patients highlighting key take-aways from the Pulmonary Fibrosis Foundation Summit 2021 in Chicago, IL. This CME series was intended for pulmonologists, cardiologists, cardiopulmonologists, radiologist, respiratory therapists, patients and caregivers, and other healthcare clinicians (MD's, PAs, and NPs) interested in managing patients with ILDs. The PFF is engaged in a multi-year federally funded research collaboration called PRECISIONS, which is laying the foundation for personalized medicine in PF. Biomarkers - biological molecules found in blood that convey information about disease status - play a critical role in PRECISIONS. This ambitious clinical trial is the first ever to apply the principles of precision medicine to the diagnosis and treatment of IPF. Data and blood from the PFF Registry are being used in the study to help rapidly identify clinical trial participants who are eligible for the study.
FORM 990, PART III, LINE 4D:OTHER PROGRAM SERVICES: PROGRAM SUPPORT/MARKETING: WE EXECUTED OUR PINPOINT PF AWARENESS CAMPAIGN TARGETING THROUGH FY 2022 AND GENERATED MORE THAN 1.57 BILLION IMPRESSIONS IN DIGITAL AND EARNED MEDIA THROUGHOUT THE YEAR. THIS CAMPAIGN TARGETED PATIENTS AND POTENTIAL PATIENTS; CAREGIVERS AND FAMILY MEMBERS; HEALTHCARE PROVIDERS; AND AT-RISK POPULATIONS. OUR FIRST MAJOR PUSH CAME IN SEPTEMBER FOR PULMONARY FIBROSIS AWARENESS MONTH (PFAM). DR. AMY HAJARI CASE, PFF SENIOR MEDICAL ADVISOR FOR EDUCATION AND AWARENESS, LED A RADIO MEDIA TOUR IN WHICH SHE COMPLETED 16 INTERVIEWS. DR. CASE REACHED LISTENERS NATIONWIDE TO RAISE AWARENESS OF EVENTS TAKING PLACE DURING PFAM AND TO ENCOURAGE INDIVIDUALS TO NOTE PF SYMPTOMS EARLY AND START CONVERSATIONS WITH THEIR DOCTORS. ADDITIONAL COVERAGE DURING PFAM FEATURED PFF AMBASSADOR AND RETIRED NYPD DETECTIVE TOM FREY WHO HELPED US SHINE A LIGHT ON PF IN TOP-TIER NATIONAL MEDIA IN CONJUNCTION WITH THE 20TH ANNIVERSARY OF 9/11. A FINAL PFAM HIGHLIGHT WAS A SATELLITE MEDIA TOUR SHOWCASING PF ADVOCATE, JULIE HALSTON, WHO RECEIVED THE 2020 ISABELLE STEVENSON TONY AWARD IN RECOGNITION OF HER CHARITABLE WORK FOR THE PFF. THE PFF'S AWARENESS CAMPAIGN SUCCESSFULLY GREW TRAFFIC TO THE ABOUTPF.ORG MICROSITES AND TO THE PFF'S WEBSITE, PULMONARYFIBROISIS.ORG. THE CAMPAIGN DROVE INQUIRIES TO THE PFF HELP CENTER. OUR MEDIA RELATIONS EFFORT PRODUCED FEATURE STORIES ON RELEVANT TOPICS THROUGHOUT THE YEAR. WE SHARED INDUSTRY NEWS ON TOPICS INCLUDING PF RESEARCH, PFF SCHOLARS, PFF POSITION STATEMENTS, AND CLINICAL TRIALS RESOURCES. PFF AMBASSADOR STORIES WERE HIGHLIGHTED IN NATIONWIDE MEDIA THROUGH COVERAGE ABOUT HILL DAY, PFF WALKS, AND TEAM PFF EVENTS. WE ALSO UTILIZED AMBASSADOR STORIES TO PROMOTE THE PFF SUMMIT 2021. WE JOINED EIGHT ORGANIZATIONS TO PRESENT THE FIRST ANNUAL ILD DAY ON SEPTEMBER 15, 2021, TO DRIVE PUBLIC AND HEALTHCARE INDUSTRY AWARENESS OF INTERSTITIAL LUNG DISEASE. IN ADDITION TO THE PFF, THIS COLLABORATION FEATURED THE ARTHRITIS FOUNDATION, FOUNDATION FOR SARCOIDOSIS RESEARCH, THE MYOSITIS ASSOCIATION, PF WARRIORS, SCLERODERMA FOUNDATION, SCLERODERMA RESEARCH FOUNDATION, SJGREN'S FOUNDATION, AND WESCOE FOUNDATION FOR PULMONARY FIBROSIS. ILD DAY PROMOTION INCLUDED A LOGO, MEDIA PLACEMENTS, A MAT RELEASE FOR COMMUNITY NEWSPAPERS, SOCIAL MEDIA AND AN ILD DAY LANDING PAGE. THIS EFFORT GENERATED MORE THAN 632 MILLION IMPRESSIONS. PULMONARY FIBROSIS AWARENESS MONTH (SEPTEMBER) IS WHEN THE PF COMMUNITY UNITES AS A COLLECTIVE VOICE TO ENHANCE DISEASE AWARENESS AND PROVIDE OUTREACH TO THOSE IN NEED. DURING PULMONARY FIBROSIS AWARENESS MONTH, THE PF COMMUNITY JOINED THE PFF AND PARTICIPATED IN THE #BLUEUP4PF CAMPAIGN, ATTENDED VIRTUAL EDUCATIONAL AND TEAM PFF EVENTS, PARTICIPATED IN WEBINARS, AND SPREAD DISEASE AWARENESS THROUGH SOCIAL MEDIA. MORE THAN 100 BUILDINGS ACROSS THE UNITED STATES SHINED BLUE, AND THE PFF REACHED MORE THAN 533,000 USERS ACROSS ALL SOCIAL MEDIA PLATFORMS. FINALLY, THE PFF HOSTED ITS VERY FIRST CLINICAL TRIALS WEEK ON SOCIAL MEDIA. IN CONJUNCTION WITH CLINICAL TRIALS DAY ON MAY 20, THE PFF HOSTED A 7-DAY CAMPAIGN, SHARING ALL ITS VALUABLE RESOURCES ABOUT CLINICAL TRIALS. THE CAMPAIGN ENCOURAGED FOLLOWERS TO LEARN ABOUT CLINICAL TRIALS AND CONSIDER USING THE FOUNDATION'S FINDER TOOL. THE CAMPAIGN RESULTED IN A 65% INCREASE TO TRIALS.PULMONARYFIBROSIS.ORG COMPARED TO PREVIOUS MONTHS AND EARNED MORE THAN 43,500 IMPRESSIONS ACROSS SOCIAL MEDIA. DUE TO THE SUCCESS OF THE CAMPAIGN, THE PFF WILL CONTINUE TO HOST CLINICAL TRIALS WEEK ON AN ANNUAL BASIS. PFF SUMMIT: PFF SUMMIT 2021 IS THE PFF'S BIENNIAL INTERNATIONAL HEALTH CARE CONFERENCE ON PULMONARY FIBROSIS (PF). THE GOAL OF THE PFF SUMMIT IS TO FOSTER A COLLABORATIVE ENVIRONMENT TO IMPROVE EDUCATION AND AWARENESS OF PF AND TO IDENTIFY NEW APPROACHES TO TREAT, AND ULTIMATELY CURE, THIS DEVASTATING DISEASE. THE PFF SUMMIT FEATURES AN INNOVATIVE CONTINUING MEDICAL EDUCATION (CME) PROGRAM FOR HEALTH CARE PROFESSIONALS AND SESSIONS FOR PF PATIENTS AND CAREGIVERS THAT ADDRESS THEIR GROWING EDUCATIONAL NEEDS. (NOTE: SOME EXPENSES FOR THE PFF SUMMIT 2021 WERE INCLUDED IN THE 2020 FORM 990). RESEARCH: THE PULMONARY FIBROSIS FOUNDATION (PFF) PLACES ENORMOUS IMPORTANCE ON CREATING AN ENVIRONMENT THAT WILL ASSIST IN THE DEVELOPMENT OF EFFECTIVE TREATMENTS FOR PULMONARY FIBROSIS (PF). IN ADDITION TO CREATING THE PFF PATIENT REGISTRY TO PROVIDE RESEARCHERS WITH DATA TO ADDRESS SPECIFIC RESEARCH QUESTIONS, WE ARE DIRECTLY FUNDING PF RESEARCH THROUGH THE PFF SCHOLARS PROGRAM, DEVELOPING LEGISLATIVE ADVOCACY EFFORTS, ENCOURAGING COLLABORATIVE RELATIONS BETWEEN INDUSTRY AND ACADEMIC RESEARCHERS, DELIVERING KEY COMMUNICATIONS TO PATIENTS, AND DEVELOPING SOLUTIONS TO BRIDGE EXISTING GAPS IN PF RESEARCH. THE PFF SCHOLARS PROGRAM SUPPORTS PROJECTS THAT OFFER A HIGH LIKELIHOOD OF IMPROVING THE UNDERSTANDING OF PF IN THE FOLLOWING RESEARCH AREAS: BASIC SCIENCE, TRANSLATIONAL, CLINICAL, EPIDEMIOLOGICAL, AND HEALTH SERVICES. THE GOAL OF THE PFF SCHOLARS PROGRAM IS TO SUPPORT EMERGING INVESTIGATORS TO ADVANCE RESEARCH THAT COULD TRANSLATE INTO SUCCESSFUL THERAPIES, WHILE ALSO ENABLING THESE PROMISING RESEARCHERS TO OBTAIN INDEPENDENT FUNDING AND CONTINUE THEIR CUTTING-EDGE RESEARCH. THE RESEARCH REVIEW COMMITTEE ADMINISTERS THE PEER-REVIEW PROCESS, WHICH IS COMPRISED OF 28 CREDIBLE EXPERTS FROM THE US AND CANADA. AFTER THEIR REVIEW AND RECOMMENDATIONS, THE PFF FUNDED FOUR $75,000 GRANTS OVER A TWO YEAR PERIOD IN THE 2021 CYCLE. THE PFF ALSO CONSIDERS OTHER SMALLER GRANTS THAT FIT THE RESEARCH GUIDELINES. ADVOCACY: THE PFF ENGAGED POLICYMAKERS TO REQUEST INCREASED FUNDING FOR PULMONARY FIBROSIS RESEARCH AND IMPROVED ACCESS TO OXYGEN FOR PATIENTS. THE PFF HOSTED A VIRTUAL HILL DAY ON MARCH 10, 2022 TO PROVIDE CONSTITUENTS WITH THE OPPORTUNITY TO MEET WITH THEIR MEMBERS OF CONGRESS AND RAISE AWARENESS ABOUT THE IMPACT OF PULMONARY FIBROSIS IN THEIR LIVES AND THE NEED FOR RESEARCH FUNDING. CONGRESS INCLUDED LANGUAGE ABOUT THE NEED FOR PULMONARY FIBROSIS RESEARCH IN THE NATIONAL HEART, LUNG, AND BLOOD INSTITUTE APPROPRIATIONS REPORT AND MAINTAINED PF AS AN ELIGIBLE TOPIC IN THE PEER REVIEWED MEDICAL RESEARCH PROGRAM. THE PFF WORKED WITH OTHER PATIENT AND PROFESSIONAL ADVOCACY GROUPS TO ADVOCATE FOR IMPROVED ACCESS TO OXYGEN FOR PATIENTS. EDUCATION: THE PULMONARY FIBROSIS FOUNDATION (PFF) IS COMMITTED TO PROVIDING QUALITY DISEASE EDUCATION TO THE PULMONARY FIBROSIS COMMUNITY. THE PFF STRIVES TO PROVIDE PATIENTS, CAREGIVERS, FAMILY MEMBERS, AND HEALTH CARE PROVIDERS WITH THE RESOURCES NECESSARY TO MORE FULLY UNDERSTAND PF AND ITS IMPACT AS WELL AS PROVIDE PATIENTS WITH THE TOOLS NECESSARY TO LIVE WITH THE DISEASE AND IMPROVE THEIR QUALITY OF LIFE. THE PFF DISEASE EDUCATION WEBINAR SERIES HAS SERVED AS AN ESSENTIAL PROGRAM TO ADVANCE OUR MISSION OF EDUCATING THE PF COMMUNITY. THE WEBINAR SERIES PROVIDES A FREE, CONVENIENT WAY FOR PATIENTS, CAREGIVERS, AND FAMILIES TO LEARN FROM AND CONNECT WITH PF SPECIALISTS ON A VARIETY OF IMPORTANT TOPICS. DURING FY 21-22, THE PFF DISEASE EDUCATION WEBINAR SERIES HOSTED EIGHT WEBINARS ALONG WITH TWO ADDITIONAL WEBINARS IN CONJUNCTION WITH THE AMERICAN THORACIC SOCIETY PUBLIC ADVISORY ROUNDTABLE. THE PFF DISEASE EDUCATION WEBINAR SERIES TOPICS INCLUDED: RESEARCH UPDATES, GENETIC COUNSELING, MULTIDISCIPLINARY CARE TEAMS, FINANCIAL ASSISTANCE PROGRAMS AVAILABLE TO PULMONARY FIBROSIS PATIENTS, PALLIATIVE CARE, AND MORE. THE PFF DISEASE EDUCATION WEBINAR SERIES HOSTED OVER 1,200 LIVE ATTENDEES. WEBINARS ARE RECORDED AND AVAILABLE FOR VIEWING ON BOTH THE PULMONARY FIBROSIS FOUNDATION WEBSITE AND YOUTUBE CHANNEL. WEBINARS FROM THE PFF DISEASE EDUCATION WEBINAR SERIES FROM THIS TIMEFRAME HAVE AMASSED OVER 7,300 VIEWS ON YOUTUBE ALONE. IN ADDITION TO THE PFF DISEASE EDUCATION WEBINAR SERIES, THE FOUNDATION HAS DEVELOPED A LIBRARY OF DISEASE EDUCATION MATERIALS FOR PULMONARY FIBROSIS PATIENTS, CAREGIVERS, FAMILY MEMBERS, AND FRIENDS. DURING FY 21-22, THE PULMONARY FIBROSIS FOUNDATION TRANSLATED A TELEMEDICINE BOOKLET AND CHECKLIST INTO HINDI AND MANDARIN LANGUAGES. SINCE THE BEGINNING OF THE COVID-19 PANDEMIC, TELEMEDICINE HAS BEEN A VITAL RESOURCE FOR CONNECTING PATIENTS WITH THEIR HEALTHCARE PROVIDERS. TRANSLATING THESE MATERIALS HELPS TO ENSURE THAT MORE PATIENTS ARE ABLE TO BENEFIT FROM THESE APPOINTMENTS AND ARE PREPARED FOR A SUCCESSFUL VISIT. ADDITIONALLY, THE PFF CREATED SEVERAL NEW FACT SHEETS AS WELL AS DOCUMENTS WITH UPDATED COVID-19 INFORMATION IN BOTH ENGLISH AND SPANISH, ALL AVAILABLE ON THE WEBSITE.
OUTREACH AND AWARENESS:THE PFF AMBASSADOR PROGRAM EMPOWERS PATIENTS, CAREGIVERS, LUNG TRANSPLANT RECIPIENTS, FAMILY MEMBERS, THOSE WHO HAVE LOST A LOVED ONE, AND HEALTH CARE PROFESSIONALS TO SERVE AS SPOKESPEOPLE FOR THE PF COMMUNITY. COMPRISING A DIVERSE AND DYNAMIC GROUP OF VOLUNTEERS FROM ACROSS THE UNITED STATES, PFF AMBASSADORS UNDERGO FORMAL TRAINING TO PREPARE FOR SPEAKING AND ADVOCATING ON BEHALF OF THE PULMONARY FIBROSIS FOUNDATION AND THE PULMONARY FIBROSIS COMMUNITY. PFF AMBASSADORS REPRESENT THE FOUNDATION AS THEY ATTEND EVENTS AROUND THE COUNTRY. EVENTS INCLUDE PFF CARE CENTER NETWORK EVENTS, SUPPORT GROUP MEETINGS, EDUCATION EVENTS, FUNDRAISERS, OTHER DISEASE AWARENESS AND EDUCATION PROGRAMS, AND A VARIETY OF MEDIA OPPORTUNITIES. PFF AMBASSADORS PROMOTE DISEASE AWARENESS, PROVIDE UP-TO-DATE INFORMATION, AND OFFER HOPE AND INSPIRATION TO THOSE AFFECTED BY PULMONARY FIBROSIS. IN OCTOBER 2021, THE PFF HOSTED A VIRTUAL MEETING ONLINE FOR VOLUNTEERS TO RECEIVE UP-TO DATE INFORMATION ON THE FOUNDATION, RESOURCES AVAILABLE, AND TRAINING FOR THEIR ROLES. THE PFF PROVIDES MONTHLY TRAINING TO PFF AMBASSADORS THROUGHOUT THE YEAR. IN APRIL 2022, THE PFF INTRODUCED THE CLASS OF 2022 AMBASSADORS CONSISTING OF 22 NEW MEMBERS TO THE PROGRAM. SUPPORT GROUPS: THE PFF SUPPORT GROUP LEADER NETWORK PROVIDES A FORUM FOR PF SUPPORT GROUP LEADERS TO CONNECT, EXCHANGE IDEAS, AND SHARE BEST PRACTICES. THE PFF'S SUPPORT GROUP LEADER NETWORK CONSISTS OF OVER 150 SUPPORT GROUPS ACROSS THE COUNTRY. THE PFF PROVIDES AN ONLINE PLATFORM FOR GROUPS TO MEET SAFELY DURING COVID-19 AND CONNECT WITH OTHERS ACROSS THE NATION. THE PFF PROVIDES PHONE-BASED VIRTUAL SUPPORT GROUPS FOR MEMBERS OF THE PF COMMUNITY WHO EITHER DO NOT HAVE A LOCAL SUPPORT GROUP OR ARE LOOKING FOR ADDITIONAL SUPPORT BETWEEN THEIR OTHER MEETINGS. THE PFF MEETINGS VARY IN TOPIC AREAS FOCUSED ON GENERAL DISEASE EDUCATION, LUNG TRANSPLANTATION, CAREGIVING, AND SPANISH SPEAKERS. THESE FOUR SUPPORT GROUPS MEET MONTHLY AND TO LEARN MORE ABOUT THEM VISIT HERE: HTTP://BIT.LY/PFFSUPPORT. IN OCTOBER 2021, THE PFF HOSTED A VIRTUAL MEETING ONLINE FOR VOLUNTEERS TO RECEIVE UP-TO DATE INFORMATION ON THE FOUNDATION, RESOURCES AVAILABLE, AND TRAINING FOR THEIR ROLES. THE PFF PROVIDES QUARTERLY TRAINING TO THE PFF SUPPORT GROUP LEADER NETWORK THROUGHOUT THE YEAR.
FORM 990, PART VI, SECTION B, LINE 11B:A COPY OF FORM 990 IS REVIEWED BY THE FINANCE COMMITTEE BEFORE FILING. THE FORM 990 IS AVAILABLE TO ALL BOARD MEMBERS BEFORE FILING THE FORM.
FORM 990, PART VI, SECTION B, LINES 12C:THE ORGANIZATION HAS A CONFLICT OF INTEREST POLICY WITHIN THE EMPLOYEE HANDBOOK AND ALL EMPLOYEES ARE REQUIRED TO ADHERE TO THE POLICY. EMPLOYEES SIGN A DISCLOSURE FORM EACH YEAR. ANNUALLY, BOARD MEMBERS ARE SENT A FORM TO FILL OUT STATING WHETHER THEY HAVE ANY CONFLICTS OF INTEREST. IF SUCH CONFLICTS EXIST, THEN THEY FILL OUT AN ADDITIONAL FORM OUTLINING THOSE CONFLICTS. THE EXECUTIVE COMMITTEE REVIEWS ANY CONFLICTS THAT ARISE.
FORM 990, PART VI, SECTION B, LINES 15A & B:CHIEF EXECUTIVE OFFICER AND CHIEF OPERATING OFFICER'S COMPENSATION WAS APPROVED BY THE EXECUTIVE COMMITTEE, WHICH SERVES AS THE COMPENSATION COMMITTEE. THIS APPROVAL WAS BASED ON A REVIEW BY AN INDEPENDENT COMPENSATION CONSULTANT AND IS SUPPORTED BY A WRITTEN EMPLOYMENT CONTRACT. THE COMMITTEE ALSO REVIEWED COMPENSATION SURVEYS AND FORM 990S OF OTHER ORGANIZATIONS TO ENSURE THE COMPENSATION WAS APPROPRIATE. THE SALARY FOR THE CHIEF MARKETING OFFICER WAS NOT REVIEWED BY THE COMPENSATION COMMITTEE, BUT THE SALARY WAS IN LINE WITH THE MARKET.
FORM 990, PART VI, SECTION C, LINE 19:THE ORGANIZATION MAKES ITS FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST AND ON THE ORGANIZATION'S WEBSITE. THE ORGANIZATION DOES NOT MAKE ITS GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY AVAILABLE TO THE PUBLIC.
FORM 990 PART IX LINE 11GDESCRIPTION:REGISTRY DCC CONSULTING TOTAL FEES:1641133
FORM 990 PART IX LINE 11GDESCRIPTION:MEDICAL CONSULTING TOTAL FEES:437708
FORM 990 PART IX LINE 11GDESCRIPTION:MARKETING CONSULTING TOTAL FEES:415289
FORM 990 PART IX LINE 11GDESCRIPTION:SITE PAYMENTS TOTAL FEES:344300
FORM 990 PART IX LINE 11GDESCRIPTION:OTHER CONSULTATIONS TOTAL FEES:336517
FORM 990 PART IX LINE 11GDESCRIPTION:MARKETING CAMPAIGN TOTAL FEES:159513
FORM 990 PART IX LINE 11GDESCRIPTION:RECRUITMENT FEES TOTAL FEES:104907
FORM 990 PART IX LINE 11GDESCRIPTION:REGISTRY HRCT COLLECTION TOTAL FEES:49235
FORM 990 PART IX LINE 11GDESCRIPTION:MERCHANT CARD CHARGES TOTAL FEES:45504
FORM 990 PART IX LINE 11GDESCRIPTION:WRITING/EDITING TOTAL FEES:34258
FORM 990 PART IX LINE 11GDESCRIPTION:GRAPHIC DESIGN TOTAL FEES:32050
FORM 990 PART IX LINE 11GDESCRIPTION:IT CONSULTING TOTAL FEES:28324
FORM 990 PART IX LINE 11GDESCRIPTION:MEDIA RELATIONS TOTAL FEES:24045
FORM 990 PART IX LINE 11GDESCRIPTION:OTHER OUTSIDE SERVICES TOTAL FEES:22366
FORM 990 PART IX LINE 11GDESCRIPTION:CME TOTAL FEES:20000
FORM 990 PART IX LINE 11GDESCRIPTION:EMPLOYEE ADMIN FEES TOTAL FEES:15028
FORM 990 PART IX LINE 11GDESCRIPTION:TRANSLATION SERVICES TOTAL FEES:11472
FORM 990 PART IX LINE 11GDESCRIPTION:STIPENDS TOTAL FEES:11200
FORM 990 PART IX LINE 11GDESCRIPTION:REGISTRY MANAGEMENT TOTAL FEES:6500
FORM 990 PART IX LINE 11GDESCRIPTION:PHOTOGRAPHY TOTAL FEES:2165
FORM 990 PART IX LINE 11GDESCRIPTION:DP CARD PROCESSING FEES TOTAL FEES:10

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.